Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: β-chemokine-dependent and -independent effects

AIDS Research and Human Retroviruses

Volumn 13, Issue 1, 1997, Pages 63-69

  Rubbert, Andrea ^a,b   Weissman, Drew ^a   Combadiere, Christophe ^a   Pettrone, Kristen A ^a   Daucher, James A ^a   Murphy, Philip M ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Building 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITY; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0031020988     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.63     Document Type: Article

References (26)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
2. Weissman D, Li Y, Orenstein JM, and Fauci AS: Both a precursor and a mature population of dendritic cells can bind HIV; however, only the mature population that expresses CD80 can pass infection to unstimulated CD4 positive T cells. J Immunol 1995;155:4111-4117.
3. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.
4. Embretson JM, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
5. + cells involves a noncytotoxic mechanism. J Virol 1991;65:5921-5927.
6. + T lymphocytes suppresses HIV replication. Immunology 1989;66:628-630.
7. +cell antiviral factor. Cell Immunol 1994;153:329-343.
8. + T cells. Immunol Today 1996;17:217-224.
9. + T cells. Evidence for a soluble inhibitor. J Immunol 1990;144:2961-2967.
10. + T cell suppressor activities. J Immunol 1996;156:4476-4483.
11. Schall TJ: Biology of the RANTES/SIS cytokine family. Cytokine 1991;3:165-183.
12. Kasama T, Strieter RM, Standiford TJ, Burdick MD, and Kunkel SL: Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha. J Exp Med 1993;178:63-72.
13. Baggiolini M, Dewald B, and Moser B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994;55:97-179.
14. Taub DD and Oppenheim JJ: Chemokines, inflammation and the immune system. Ther Immunol 1994;1:229-246.
15. + T cells. Science 1995;270:1811-1815.
16. Sallusto F and Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.
17. + cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991;87:1462-1466.
18. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-1566.
19. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin-8 and RANTES. Eur J Immunol 1995;25:751-756.
20. Stellato C, Beck LA, Gorgone GA, Proud D, Schall TJ, Ono SJ, Lichtenstein LM, and Schleimer RP: Expression of the chemokine RANTES by a human bronchial epithelial cell line. J Immunol 1995;155:410-418.
21. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, and Koup RA: Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 1996;2:412-417.
22. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
23. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PA, Murphy PM, and Berger EA: CC CKR5: A RANTES, MIP-1α and MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
24. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mckay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
25. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, and Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
26. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miederha F, and Tersmette M: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 1992;66:1354-1360.